Literature DB >> 24462403

Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine.

Chiara Tani1, Maria Stella1, Danilo Donnarumma1, Massimiliano Biagini1, Pierino Parente1, Alessandro Vadi1, Claudia Magagnoli1, Paolo Costantino1, Fabio Rigat1, Nathalie Norais2.   

Abstract

Meningococcal disease is a major cause of morbidity and mortality worldwide. Its epidemiology is currently dominated by five capsular serogroups (A, B, C, W, and Y). While effective vaccines already exist for serogroups A, C, W and Y, except for under clonal outbreaks, no vaccine was available against serogroup B. Recently, a four component vaccine, Bexsero(®), designed to prevent infection caused by this serogroup, has been approved in Europe and other Countries for use in individuals from two months of age and older. The active components of this vaccine are three recombinant proteins identified by reverse vaccinology combined with detergent extracted outer membrane vesicles (DOMV) prepared from a New Zealand epidemic strain. Considering their intrinsic complexity, we performed additional characterization of DOMVs on top of the standard quality control testing carried out for batch release. We applied the Hi3 label-free LC-MS(E) methodology to qualitatively and quantitatively characterize the DOMV protein content. We first, successfully investigated the robustness and the accuracy of the methodology for the DOMV characterization and we then applied it to compare six DOMV production lots. Around 100 proteins were quantified from each preparation. When classified according to their predicted cellular localization, about 90% of the total protein amount belongs consistently to the outer membrane compartment. Using nonparametric hypothesis testing and complementary log-log linear regression, the quantifications of a subset of 21 proteins common to all lots and including approximately 90% (85-92%) of the total protein amount quantified in any DOMV lot were found consistent across lots. The relevance of these results is two-fold, showing that the Hi3 quantification methodology is robust for a broad range of proteins and indicating that the manufacturing process currently used for the production of the Bexsero(®) DOMV components is highly reproducible and consistent.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bexsero(®); Neisseria meningitidis; Outer membrane vesicles; Quantitative proteomics; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 24462403     DOI: 10.1016/j.vaccine.2014.01.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

Review 1.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

Review 2.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

3.  Label-free quantitative mass spectrometry for analysis of protein antigens in a meningococcal group B outer membrane vesicle vaccine.

Authors:  Lawrence W Dick; John T Mehl; John W Loughney; Anna Mach; Richard R Rustandi; Sha Ha; Lan Zhang; Craig T Przysiecki; Lance Dieter; Van M Hoang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model.

Authors:  Carolyn M Buckwalter; Elissa G Currie; Raymond S W Tsang; Scott D Gray-Owen
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

5.  Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells.

Authors:  Hong Wang; Sam Hanash
Journal:  Methods       Date:  2015-03-17       Impact factor: 3.608

6.  Methods for Assessment of OMV/GMMA Quality and Stability.

Authors:  Francesca Micoli; Renzo Alfini; Carlo Giannelli
Journal:  Methods Mol Biol       Date:  2022

7.  Infection With the US Neisseria meningitidis Urethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea.

Authors:  Abigail Norris Turner; Alexandria M Carter; Yih-Ling Tzeng; David S Stephens; Morgan A Brown; Brandon M Snyder; Adam C Retchless; Xin Wang; Jose A Bazan
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999

8.  LytM proteins play a crucial role in cell separation, outer membrane composition, and pathogenesis in nontypeable Haemophilus influenzae.

Authors:  Giuseppe Ercoli; Chiara Tani; Alfredo Pezzicoli; Irene Vacca; Manuele Martinelli; Simone Pecetta; Roberto Petracca; Rino Rappuoli; Mariagrazia Pizza; Nathalie Norais; Marco Soriani; Beatrice Aricò
Journal:  MBio       Date:  2015-02-24       Impact factor: 7.867

9.  Outer Membrane Vesicles (OMV)-based and Proteomics-driven Antigen Selection Identifies Novel Factors Contributing to Bordetella pertussis Adhesion to Epithelial Cells.

Authors:  Gianmarco Gasperini; Massimiliano Biagini; Vanessa Arato; Claudia Gianfaldoni; Alessandro Vadi; Nathalie Norais; Giuliano Bensi; Isabel Delany; Mariagrazia Pizza; Beatrice Aricò; Rosanna Leuzzi
Journal:  Mol Cell Proteomics       Date:  2017-12-04       Impact factor: 5.911

Review 10.  Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines.

Authors:  Helen Petousis-Harris; Fiona J Radcliff
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.